Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy: Executive Summary

Journal of Obstetrics and Gynaecology Canada

Volumn 36, Issue 7, 2014, Pages 575-

  Somerset, David ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; LABETALOL; METHYLDOPA; NIFEDIPINE;

CLINICAL EVALUATION; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; HUMAN; LETTER; MATERNAL HYPERTENSION; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; SYSTOLIC BLOOD PRESSURE; FEMALE; HYPERTENSION, PREGNANCY-INDUCED; PREGNANCY;

FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; PRACTICE GUIDELINES AS TOPIC; PREGNANCY;

EID: 84922327752     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(15)30532-6     Document Type: Letter

References (3)

1. Magee L.A., Pels A., Helewa M., Rey E., von Dadelszen P., SOGC Hypertension Guideline Committee Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. SOGC Clinical Practice Guideline No. 307, May 2014. J Obstet Gynaecol Can 2014, 36(5):416-438.
2. Drug Information (Lexicomp). UpToDate. Waltham, MA. Available at: . Accessed May 6, 2014. http://www.uptodate.com/home/drugs-drug-interaction.
3. Martin J.N., Thigpen B.D., Moore R.C., Rose C.H., Cushman J., May W. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol 2005, 105(2):246.